Overview
Biocourse.Pl is BioLegend’s official distributor in Poland, supplying antibodies and reagents for research and diagnostics. Since 2013, it has supported Polish science with technical assistance and product-selection advice for fields including oncology, neurology and immunology.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $3,024 |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 426 days for 2020).
- 202515/07/2026
- 202416/07/2025
- 202317/07/2024
- 202217/07/2023
- 202119/10/2022
- 202015/12/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Antibodies
- Recombinant proteins
- ELISA kits
- Multiplex assays
- Flow cytometry reagents
- Cell biology products
- Microscopy reagents
Public procurement
37 tenders recorded as contractor: 25 national ($539,695) and 12 EU ($105,889).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 28, 2026 | Supply of recombinant proteins, peptides and reagents for detection and diagnostics, divided into 7 lots, for Łukasiewicz-PORT under a framework agreement | –– | Sieć Badawcza Łukasiewicz - Port Polski Ośrodek Rozwoju Technologii | |
| Sep 22, 2026 | Supply of reagents for cell biology, recombinant proteins and peptides, chemicals for highly specialized research applications and basic chemical compounds for laboratory | –– | Instytut Medycyny Doświadczalnej i Klinicznej Im. Mirosława Mossakowskiego Pan | |
| Jul 27, 2026 | 177_Successive supply of laboratory and chemical reagents used in scientific research | $648$648 | Instytut Podstawowych Problemów Techniki Pan |
Authorized Representatives
Manner of representation
The company is represented by each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dariusz Jastrzębskiage 66 | 99 | $1,337.12 | 99% |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-11-18.
81 1600 1462 1080 9875 8000 0001- 81 1750 0012 0000 0000 3537 3284
- 54 1600 1462 1080 9875 8000 0002
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $5,589.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $615$615 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $615$615 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,077$3,077 | Polski Fundusz Rozwoju S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Mediqurs Bissp. z o.o. | $1,391,010.74 | mediqursbis.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Polsil Biopreparatysp. z o.o. | $952,024.30 | polsil.pl | ||
| LabooS.K.A. | $887,013.54 | drogerielaboo.pl | ||
| Biotic Biomesp. z o.o. | $689,147.75 | bioticbiome.pl | ||
| Polygensp. z o.o. | $575,907.38 | polygen.pl | ||
| Support-Pharmasp. z o.o. | $521,132.71 | support-pharma.pl | ||
| Tecnobody Polskasp. z o.o. | $508,641.92 | mtt.net.pl | ||
| Biocomsp. z o.o. | $433,929.05 | biocom.net.pl | ||
| Medcellsp. z o.o. | $339,369.93 | medcell.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-04-06 | Name change (Biocourse.pl Dariusz Jastrzębski → Biocourse.pl) | |
| 2016-11-09 | Entered in the register |
FAQ
Last updated: 2026-07-15